# Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV

> **NCT00295477** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 25 (estimated)

## Conditions studied

- HIV

## Interventions

- **GENETIC:** VRX496

## Key facts

- **NCT ID:** NCT00295477
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2010-04
- **Final completion:** 2013-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2019-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295477, "Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00295477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*